Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetic Research Instrumentation (GRI) was a prominent UK-based provider of specialist instrumentation and consumables for the life science and drug discovery markets. The company focused on delivering technologies for molecular biology, including gel documentation systems, PCR thermal cyclers, and liquid handling solutions. GRI served as a key distributor for several international biotechnology brands while also developing its own branded laboratory products. In 2010, the company was acquired by Labtech International, which integrated GRI's product portfolio and technical expertise into its own operations to expand its presence in the UK and European research sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genetic Research Instrumentation.